tumor antigen vaccine (AAV vector) (Aavet Therapeutics)

N/A

Report date: 2025/01/26 17:28:11

Base Information

Drug Nametumor antigen vaccine (AAV vector) (Aavet Therapeutics)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAavet Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesAavet Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A